Bolt Biotherapeutics Inc
(BOLT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2013 | 12-2012 | 09-2012 | 06-2012 | 03-2012 | |
| Sales | 11,243 | 14,410 | 14,268 | 15,457 | 12,993 |
| Cost of Goods | 5,674 | 8,009 | 7,670 | 8,139 | 7,005 |
| Gross Profit | 5,569 | 6,401 | 6,598 | 7,318 | 5,988 |
| Operating Expenses | 4,306 | 3,943 | 4,675 | 4,163 | 3,813 |
| Operating Income | 1,937 | 2,467 | 2,593 | 3,294 | 2,180 |
| Other Income | 40 | 37 | 28 | -4,478 | 30 |
| Pre-tax Income | 1,977 | 2,504 | 2,621 | -1,184 | 2,210 |
| Income Tax | 596 | 803 | 917 | 1,085 | 625 |
| Net Income Continuous | 1,381 | 1,701 | 1,704 | -2,269 | 1,585 |
| Net Income | $1,381 | $1,701 | $1,704 | $-2,269 | $1,585 |
| EPS Basic Total Ops | 0.16 | 0.20 | 0.20 | -0.26 | 0.18 |
| EPS Basic Continuous Ops | 0.16 | 0.20 | 0.20 | -0.27 | 0.18 |
| EPS Diluted Total Ops | 0.16 | 0.20 | 0.20 | -0.26 | 0.18 |
| EPS Diluted Continuous Ops | 0.16 | 0.20 | 0.20 | -0.27 | 0.18 |
| EBITDA(a) | $2,339 | $2,895 | $3,016 | $3,713 | $2,604 |